The phase III SKYSCRAPER-01 trial in PD-L1-high NSCLC failed to meet its primary endpoints of overall survival and progression-free survival, while the SKYSCRAPER-02 trial in extensive-stage small cell lung cancer also did not reach statistical significance for its primary endpoints [ 66 ].
← all excerpts
Integrated bulk and single-cell transcriptomic profiling reveals NECTIN-TIGIT interaction underlies T cell exhaustion in papillary thyroid carcinoma.
1
—
—